- Open Access
Low fish oil intake improves insulin sensitivity, lipid profile and muscle metabolism on insulin resistant MSG-obese rats
- Ricardo K Yamazaki1Email author,
- Gleisson AP Brito1,
- Isabela Coelho1,
- Danielle CT Pequitto1,
- Adriana A Yamaguchi1,
- Gina Borghetti1,
- Dalton Luiz Schiessel1,
- Marcelo Kryczyk1,
- Juliano Machado1,
- Ricelli ER Rocha1,
- Julia Aikawa1,
- Fabiola Iagher1,
- Katya Naliwaiko1,
- Ricardo A Tanhoffer1,
- Everson A Nunes2 and
- Luiz Claudio Fernandes1
© Yamazaki et al; licensee BioMed Central Ltd. 2011
- Received: 15 March 2011
- Accepted: 28 April 2011
- Published: 28 April 2011
Obesity is commonly associated with diabetes, cardiovascular diseases and cancer. The purpose of this study was to determinate the effect of a lower dose of fish oil supplementation on insulin sensitivity, lipid profile, and muscle metabolism in obese rats.
Monosodium glutamate (MSG) (4 mg/g body weight) was injected in neonatal Wistar male rats. Three-month-old rats were divided in normal-weight control group (C), coconut fat-treated normal weight group (CO), fish oil-treated normal weight group (FO), obese control group (Ob), coconut fat-treated obese group (ObCO) and fish oil-treated obese group (ObFO). Obese insulin-resistant rats were supplemented with fish oil or coconut fat (1 g/kg/day) for 4 weeks. Insulin sensitivity, fasting blood biochemicals parameters, and skeletal muscle glucose metabolism were analyzed.
Obese animals (Ob) presented higher Index Lee and 2.5 fold epididymal and retroperitoneal adipose tissue than C. Insulin sensitivity test (Kitt) showed that fish oil supplementation was able to maintain insulin sensitivity of obese rats (ObFO) similar to C. There were no changes in glucose and HDL-cholesterol levels amongst groups. Yet, ObFO revealed lower levels of total cholesterol (TC; 30%) and triacylglycerol (TG; 33%) compared to Ob. Finally, since exposed to insulin, ObFO skeletal muscle revealed an increase of 10% in lactate production, 38% in glycogen synthesis and 39% in oxidation of glucose compared to Ob.
Low dose of fish oil supplementation (1 g/kg/day) was able to reduce TC and TG levels, in addition to improved systemic and muscle insulin sensitivity. These results lend credence to the benefits of n-3 fatty acids upon the deleterious effects of insulin resistance mechanisms.
- Glycogen Synthesis
- Obese Animal
- Monosodium Glutamate
- Normal Weight Group
- Systemic Insulin Resistance
The number of obese adults and children around the world has grown dramatically in the past years. This is a major concern for public health, since, obesity is commonly associated to other conditions such as cardiovascular disease (CVD), type 2 diabetes and some types of cancer . Physical inactivity and high-fat diets , may be considered the main causes for the increased incidence of overweight and obesity. In fact, obesity has been strongly associated with metabolic syndrome (MS), which refers to a clustering of CVD risk factors including insulin resistance, type 2 diabetes, dyslipidaemia and hypertension .
The obesity model induced by monosodium glutamate (MSG) has demonstrated some of the clinical features observed in individuals with MS . The monosodium glutamate injected subcutaneously in neonatal period causes hypothalamic damage , and as a consequence, these animals present several neuroendocrine and metabolic alterations, which leads to higher levels of adipose tissue accumulation, insulin resistance and hyperinsulinemia . So the use of this model may add new information concerning the effects of possible treatments for both obesity and risk factor for CVD commonly observed in MS.
Polyunsaturated fatty acids such as n-6 is largely available in high-fat diets, and epidemiological studies have shown that increased ratio of n-6 to n-3 fatty acids in diet has been proportionally related to increased incidence of type 2 diabetes, CVD, and inflammatory diseases [7, 8]. Yet, recent evidence has also linked intake of saturated fats (i.e. coconut fat), with development of obesity . Conversely, dietary intake of fish oil, which presents high amounts of n-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has presented beneficial effects on diabetes and obesity . Several studies have examined the effects of n-3 PUFA on the prevention of insulin resistance [11, 12], however, few data have shown improvement in insulin resistance conditions owing to dietary fish intake . In addition, the concentration of fish oil used in most studies are high (7 wt% or more) and further future studies are important to determine the efficacy of lower concentrations of fish oil. Although the effects of fish oil supplementation on insulin resistance and dyslipidemia have been previously reported, results in this area are still inconclusive. Therefore, the aim of this study was to investigate the effects of lower concentration of fish oil supplementation on fasting lipid profile, insulin resistance and skeletal muscle glucose metabolism of obese rats induced by monosodium glutamate.
Obesity parameters and insulin sensitivity
Fatty acid composition of diet and oils
Fatty acids (g/100 g of total fatty acids)
1.2 ± 0.05
5.8 ± 0.6
30.8 ± 1.1
16.1 ± 0.2
22.24 ± 2.6
20.9 ± 1.3
48.9 ± 1.1
3.1 ± 0.3
1.8 ± 0.3
1.9 ± 0.2
17.3 ± 0.4
9.1 ± 0.5
7.9 ± 0.2
51.6 ± 2.4
2.4 ± 0.6
2.0 ± 0.2
5.3 ± 0.5
0.9 ± 0.01
0.2 ± 0.05
9.7 ± 0.1
0.2 ± 0.04
20.9 ± 1.2
0.7 ± 0.06
26.35 ± 3.1
Food consumption (g/100 g)
Epididymal AT (g/100 g)
Retroperitoneal AT (g/100 g)
314.00 ± 2.89
367.50 ± 7.50
7.27 ± 0.11
0.85 ± 0.06
0.96 ± 0.10
314.7 ± 2.44
371.70 ± 6.70
7.03 ± 0.11
1.00 ± 0.05
1.10 ± 0.07
313.00 ± 2.17
375.00 ± 6.31
7.18 ± 0.15
0.89 ± 0.06
1.02 ± 0.09
326.60 ± 4.19*
311.00 ± 8.14*
7.16 ± 0.19
2.06 ± 0.15*
2.45 ± 0.12*
332.00 ± 3.87
310.00 ± 10.19
6.73 ± 0.16
2.02 ± 0.12
2.50 ± 0.13
325.40 ± 2.74
312.90 ± 7.10
6.96 ± 0.18
2.13 ± 0.13
2.70 ± 0.14
FO group revealed increased skeletal muscle glycogen synthesis by 50% without insulin stimulus (p < 0.05) (Figure 3B). In obese group without supplementation (Ob), the glycogen synthesis was not different when compared to C group. ObFO presented a 40% increase in glycogen synthesis when compared to Ob group (p < 0.05). Insulin increased glycogen synthesis by 66% in C group (p < 0.05). Nevertheless, the basal condition on glycogen synthesis was high in the FO group and no additional effect was observed in the presence of insulin (p > 0.05). In CO plus insulin group, synthesis of glycogen was similar to basal conditions. The Ob group plus insulin increased the glycogen synthesis by 38% when compared to basal conditions (p < 0.05). On supplemented groups (ObFO and ObCO) plus insulin, fish oil and coconut fat increased by 36% and 45%, respectively, when compared to absence of stimuli (p < 0.05).
FO increased the glucose oxidation of skeletal muscle by 42% in basal condition when compared to control group (p < 0.05) (Figure 3C). CO did not cause any effect, as well as the obesity condition supplemented or not (p > 0.05). Insulin increased the glucose oxidation by 32% on C group when compared to basal condition (p < 0.05). FO also increased by 31% glucose oxidation in the presence of insulin (p < 0.05) when compared to C+I group, while coconut fat supplementation did not cause any effect. In Ob group plus insulin, glucose oxidation was increased by 45% when compared to basal conditions (p < 0.05). ObFO plus insulin also increased by 71% when compared to basal conditions (p < 0.05).
The obese animals presented higher Lee index and increase of fat depots (Table 2). These results confirm the obesity induction by glutamate monosodium and corroborate previous studies [14, 15]. Several metabolic changes of this model occur due to hypothalamic lesions, mainly on the arcuate nucleus . These lesions result in impaired insulin signaling and reduction of GHRH (Growth Hormone Releasing Hormone), which is associated with body length reduction also related to reduction of body weight (Table 2). This model also presents reduction of sympathetic activity and low HSL (Hormone Senstive Lipase) activity which is an enzyme with a role in the triacyglycerol hydrolysis . These alterations in adipose tissue metabolism may explain the high quantities found in epididymal and retroperitoneal adipose tissues (Table 2). Thus, the MSG rats have been used for studies of obesity because they usually present insulin resistance and high depots of fat [17–21]. Interestingly, there are no reports on employing this model to examine the effects of fish oil supplementation.
Rats fed under an isocaloric high fat diet plus 7% of fish oil showed improved insulin sensitivity quantified by euglycemic-hyperinsulinemic glucose clamp . Andersen and coworkers showed reduction of glycemy and improved insulin sensitivity by HOMA test after oral supplementation of EPA or DHA (0.5 g/kg) for 8 weeks . Our study corroborates these previous finding, showing the ability of fish oil supplementation to improve insulin sensitivity in obese animals. In contrast, Gillam and coworkers did not find any effect of the fish oil (10%) added to diet on insulin resistance, pancreatic function and glucose metabolism . The discrepancy between these results may be due the concentration of fish oil added to diet and models used, i.e., high fat and/or high-sucrose diets to induce obesity, or genetically obesity models.
Dyslipidaemia is a common feature in diabetic people and it is strongly associated with the development of atherosclerosis . The MSG rats presented higher levels of TG and cholesterol, as previously described . Lipoproteins rich in TG play a role in inflammatory process through NF-κB activation . Thus, the reduction of TG levels found within this study and others [26, 27] is an important factor which might explain part of the beneficial effects of n-3 fatty acids on cardiovascular diseases. Hypercholesterolemia increases the expression of adhesion molecules involved in atherogenesis . Our study also showed the ability of fish oil to reduce cholesterol levels of obese rats.
Skeletal muscle is the principal site of glucose metabolism and represents 40 to 50% of the total body mass. Nevertheless, to best of our knowledge, there is no report about the changes on muscle metabolism of the MSG rats. Analyzing the results from muscle metabolism responses and comparing them to systemic insulin resistance, data might seem paradoxal. There are possible reasons for these findings. First, the results from systemic insulin resistance may be influenced by several factors, besides the muscle, such as free fatty acids , cytokines  and other insulin targets like adipose tissue and liver . Second, a state of hyperinsulinemia usually found in this model could result in the increase of cell metabolism for a short period . D'Alessandro and coworkers showed that fed rats with a diet plus 7% fish oil increased insulin sensitivity of skeletal muscle . This study also found that under insulin stimuli, the glycolytic pathway was more activated rather than oxidation and storage components of glucose metabolism. This result differs from the data herein reported, probably owing to different deployed methodologies i.e. muscle type and enzymes analyzed. Interestingly, our study is the first to report these effects using a lower dose (1 g/kg/day) orally administrated on obese rats induced by MSG.
In conclusion, fish oil supplementation was able to reduce triacylglycerols and cholesterol levels, in addition to improvement in systemic and muscle insulin sensitivity. These results show that n-3 fatty acids might have crucial role in preventing and reversing insulin restance.
All enzymes and reagents for buffers were obtained from Sigma Chemical (St. Louis, MO). Fish oil was purchased from Herbarium (Parana, Brazil), coconut fat from Refino de Oleos (Bahia, Brazil), and standard chow (Nuvilab CR-1) diet from Nuvital Nutrientes (Curitiba, Brazil). Macronutrients of standard chow presented 63.4% carbohydrates, 25.6% of proteins and 11% of lipids. Fatty acid composition of the oils and chow was determined by high-performance liquid chromatographer as described previously . Briefly, total lipids were extracted from oils and chow using chloroform-methanol (2:1 vol/vol) according to Folch et al.  and free fatty acids were obtained by saponification. Fatty acids were than derivatized with 4-bromomethyl-7-coumarin and then separated by high performance liquid chromatograph (Varian ProStar) using an octadecylsilica column (25 cm × 4, 6 mm i.d.; particle size 5 mm). Fatty acids were resolved isocratically using a mobile phase of acetonitrile-water (gradient from 77:23 to 90:10 vol/vol) and fatty acid derivatives were detected by fluorescence (325-nm excitation; 395-nm emission).
Animal model and supplementation
Wistar rats were provided by the Experimental Breeding Center of the Federal University of Parana. All animal procedures were approved by the Ethical Committee of Animal Research, Sector of Biological Sciences, Federal University of Parana. Monosodium glutamate (MSG) (4 mg/g body weight) was subcutaneously injected during the first 5 days after birth. Control animals received equimolar solution of saline. On the 21st day, animals were weaned and housed under control conditions, in a 12-h light-dark inverted cycle (10 am. to 10 pm.) and 22 ± 2°C temperature. Water and standard chow were supplied ad libitum. At 90 days of age, animals were anesthetized with penthobarbital (50 mg/kg) followed by intravenous insulin test to confirm insulin resistance. After, groups were divided in control (C), fish oil supplemented (FO), coconut fat supplemented (CO), obese (Ob), obese fish oil supplemented (ObFO) and obese coconut fat supplemented (ObCO). Supplemented groups received oral administration provided as a single bolus daily using a micropipette of fish oil or coconut fat (1 g/kg/day) for 4 weeks.
Body weight and food intake were recorded every other day. At the end of the supplementation period, another intravenous insulin test was performed. After an overnight fasting, animals were anesthetized and killed by decapitation. After centrifugation, plasma samples were assayed for analysis of plasma biochemicals. Tissue samples were collected and kept at -80°C for subsequent analysis.
The index Lee [body weight (g)1/3 by the naso-anal length (cm) × 1000] was used as a parameter to evaluate the degree of obesity 
Insulin tolerance test
For estimation of in vivo insulin sensitivity, insulin was injected intravenously (0.75 U/kg body weight) in 12 h-fasted obese and non-obese rats. Afterwards, tail blood samples were collected at 0, 4, 8, 12 and 16 minutes. The rate for blood glucose disappearance was calculated based on the linear regression of the blood glucose concentrations obtained from 0 to 16 min of the test .
Analysis of biochemical plasma parameters
Enzymatic colorimetric assay kits adapted for a microplate reader (Infinite 200 TECAN) were used to determine fasting plasma glucose, triacylglycerol and total cholesterol. Enzyme immunoassay kit (SPI-Bio Bertin Pharma, Montigny le Bretonneux, France) was used to measure fasting plasma insulin.
Lactate production by incubated tissue
Under penthobarbital anesthesia (50 mg/kg), rats were killed by cervical dislocation, and soleus muscles were isolated, split longitudinally in portions weighing 20 to 30 mg. The muscles were preincubated in a water-bath, gently agitated, for 30 min at 37°C in Krebs-Ringer (KR) bicarbonate buffer, pH 7.4, pregassed for 30 min with 95% O2 - 5% CO2, containing 5.6 mM glucose and 1% BSA. After preincubation, muscles were transferred to the same buffer under similar conditions for 1 hour, in the absence or presence of 10 mU/mL insulin. At the end of incubation period, lactate from the medium was determined as previously described .
D-[U-14C] glucose incorporation to glycogen and oxidation to CO2 by incubated skeletal muscle
Following the same incubation procedures, muscles were transferred to other vials containing the same buffer, but added 0.3 Ci/mL D-[U-14C] glucose. One hour incubation was performed in the absence or presence of insulin (10 mU/mL) to the KR buffer, muscles were digested in KOH solution and glycogen synthesis determined as previously described. Phenylethylamine, diluted 1:1 v/v in methanol, was added into a separate compartment for 14CO2 adsortion and D-[U-14C] glucose oxidation. [14C]-glycogen synthesis (estimated by [D-14C]-glucose incorporation into glycogen) was determined as described by Espinal et al.
Data was tested for normal distribution with D'Agostino-Pearson test and differences between groups were analysed using unpaired t-test and one-way analysis of variance (ANOVA) followed by post hoc Tukey test. A value of p < 0.05 was taken to indicate statistical significance (Graphpad PRISM). All results are expressed as the mean ± standard error mean (SEM).
The authors acknowledge funding support from CAPES and National Counsel of Technological and Scientific Development (CNPq).
- Wisse BE, Kim F, Schwartz MW: Physiology. An integrative view of obesity. Science. 2007, 318: 928-929. 10.1126/science.1148032View ArticlePubMedGoogle Scholar
- Hill JO, Peters JC: Environmental contributions to the obesity epidemic. Science. 1998, 280: 1371-1374. 10.1126/science.280.5368.1371View ArticlePubMedGoogle Scholar
- Moller DE, Kaufman KD: Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med. 2005, 56: 45-62. 10.1146/annurev.med.56.082103.104751View ArticlePubMedGoogle Scholar
- Cunha NV, Abreu SB, Panis C, Grassiolli S, Guarnier FA, Cecchini R, Mazzuco TL, Pinge-Filho P, Martins-Pinge MC: Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats. Life Sci. 2010, 87: 375-381. 10.1016/j.lfs.2010.07.014View ArticlePubMedGoogle Scholar
- Holzwarth-McBride MA, Sladek JR, Knigge M: Monosodium glutamate induced lesions of the arcuate nucleus. II. Fluorescence histochemistry of catecholamines. Anat Rec. 1976, 186: 197-205. 10.1002/ar.1091860206View ArticlePubMedGoogle Scholar
- Hirata AE, Andrade IS, Vaskevicius P, Dolnikoff MS: Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res. 1997, 30: 671-674.View ArticlePubMedGoogle Scholar
- Simopoulos AP: Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006, 60: 502-507. 10.1016/j.biopha.2006.07.080View ArticlePubMedGoogle Scholar
- Simopoulos AP: Omega-6/omega-3 fatty acid ratio and trans fatty acids in non-insulin-dependent diabetes mellitus. Ann N Y Acad Sci. 1997, 827: 327-338. 10.1111/j.1749-6632.1997.tb51845.xView ArticlePubMedGoogle Scholar
- Storlien LH, Higgins JQ, Thomas TC, Brown MA, Wang HQ, Huang F, Else PL: Diet composition and insulin action in animal models. Br J Nutr. 2000, 83 (1): S85-90.PubMedGoogle Scholar
- Lombardo YB, Chicco AG: Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem. 2006, 17: 1-13. 10.1016/j.jnutbio.2005.08.002View ArticlePubMedGoogle Scholar
- Perez-Matute P, Perez-Echarri N, Martinez JA, Marti A, Moreno-Aliaga MJ: Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem. 2006, 17: 1-13. 10.1016/j.jnutbio.2005.08.002View ArticleGoogle Scholar
- Andersen G, Harnack K, Erbersdobler HF, Somoza V: Dietary eicosapentaenoic acid and docosahexaenoic acid are more effective than alpha-linolenic acid in improving insulin sensitivity in rats. Ann Nutr Metab. 2008, 52: 250-256. 10.1159/000140518View ArticlePubMedGoogle Scholar
- Lombardo YB, Hein G, Chicco A: Metabolic syndrome: effects of n-3 PUFAs on a model of dyslipidemia, insulin resistance and adiposity. Lipids. 2007, 42: 427-437. 10.1007/s11745-007-3039-3View ArticlePubMedGoogle Scholar
- Macho L, Fickova M, Jezova , Zorad S: Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Physiol Res. 2000, 49 (1): S79-85.PubMedGoogle Scholar
- Grassiolli S, Gravena C, de Freitas Mathias PC: Muscarinic M2 receptor is active on pancreatic islet from hypothalamic obese rat. Eur J Pharmacol. 2007, 556: 223-228. 10.1016/j.ejphar.2006.11.022View ArticlePubMedGoogle Scholar
- de Andrade IS, Gonzalez JC, Hirata AE, Carneiro G, Amado D, Cavalheiro EA, Dolnikoff MS: Central but not peripheral glucoprivation is impaired in monosodium glutamate-treated rats. Neurosci Lett. 2006, 398: 6-11. 10.1016/j.neulet.2005.12.043View ArticlePubMedGoogle Scholar
- Dolnikoff M, Martin-Hidalgo A, Machado UF, Lima FB, Herrera E: Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. Int J Obes Relat Metab Disord. 2001, 25: 426-433. 10.1038/sj.ijo.0801517View ArticlePubMedGoogle Scholar
- Hirata AE, Andrade IS, Vaskevicius P, Dolnikoff MS: Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res. 1997, 30: 671-674.View ArticlePubMedGoogle Scholar
- Larsen PJ, Fledelius C, Knudsen LB, Tang-Christensen M: Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes. 2001, 50: 2530-2539. 10.2337/diabetes.50.11.2530View ArticlePubMedGoogle Scholar
- Seraphim PM, Nunes MT, Machado UF: GLUT4 protein expression in obese and lean 12-month-old rats: insights from different types of data analysis. Braz J Med Biol Res. 2001, 34: 1353-1362. 10.1590/S0100-879X2001001000018View ArticlePubMedGoogle Scholar
- Furuya DT, Poletto AC, Favaro RR, Martins JO, Zorn TM, Machado UF: Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice. Metabolism. 2010, 59: 395-399. 10.1016/j.metabol.2009.08.011View ArticlePubMedGoogle Scholar
- Neschen S, Morino K, Dong J, Wang-Fischer Y, Cline GW, Romanelli AJ, Rossbacher JC, Moore IK, Regittnig W, Munoz DS, Kim JH, Shulman GI: N-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner. Diabetes. 2007, 56: 1034-1041. 10.2337/db06-1206View ArticlePubMedGoogle Scholar
- Gillam M, Noto A, Zahradka P, Taylor CG: Improved n-3 fatty acid status does not modultae insulin resistance in fa/fa Zucker rats. Prostaglandins Leukot Essent Fatty Acids. 2009, 81: 331-339. 10.1016/j.plefa.2009.09.008View ArticlePubMedGoogle Scholar
- Mooradian AD: Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009, 5: 150-159. 10.1038/ncpendmet1066View ArticlePubMedGoogle Scholar
- Libby P: Fat fuels the flame: triglyceride-rich lipoproteins and arterial inflammation. Circ Res. 2007, 100: 299-301. 10.1161/01.RES.0000259393.89870.58View ArticlePubMedGoogle Scholar
- Qi K, Fan C, Jiang J, Zhu H, Jiao H, Meng Q, Deckelbaum RJ: Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles. Clin Nutr. 2008, 27: 424-430. 10.1016/j.clnu.2008.02.001View ArticlePubMedGoogle Scholar
- Hassanali Z, Ametaj B, Field CJ, Proctor SD, Vine DF: Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat. Diabetes Obes Metab. 2010, 12: 139-147. 10.1111/j.1463-1326.2009.01130.xView ArticlePubMedGoogle Scholar
- Steinberg D: Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med. 2002, 8: 1211-1217. 10.1038/nm1102-1211View ArticlePubMedGoogle Scholar
- Rosen ED, Spiegelman : Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006, 444 (7121): 847-853. 10.1038/nature05483PubMed CentralView ArticlePubMedGoogle Scholar
- Guilherme A, Virbasius JV, Puri V, Cwech MP: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008, 9 (5): 367-377. 10.1038/nrm2391PubMed CentralView ArticlePubMedGoogle Scholar
- Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001, 414 (6865): 799-806. 10.1038/414799aView ArticlePubMedGoogle Scholar
- Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006, 444 (7121): 840-846. 10.1038/nature05482View ArticlePubMedGoogle Scholar
- D'Alessandro ME, Lombardo YB, Chicco A: Effect of dietary fish oil on insulin sensitivity and metabolic fate of glucose in the skeletal muscle of normal rats. Ann Nutr Metab. 2002, 46: 114-120. 10.1159/000063079View ArticlePubMedGoogle Scholar
- Naliwaiko K, Araujo RL, da Fonseca RV, Castilho JC, Andreatini R, Bellissimo MI, Oliveira BH, Martins EF, Curi R, Fernandes LC, Ferraz : Effects of fish oil on the central nervous system: a new potential antidepressant?. Nutr Neurosci. 2004, 7: 91-99. 10.1080/10284150410001704525View ArticlePubMedGoogle Scholar
- Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957, 226: 497-509.PubMedGoogle Scholar
- Bernardis LL, Patterson BD: Correlation between 'Lee Index' and carcas fat content in weanling and adult female rats with hypothalamic lesions. J Endocrinol. 1968, 40: 527-5528. 10.1677/joe.0.0400527View ArticlePubMedGoogle Scholar
- Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M: Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab. 1989, 68: 374-378. 10.1210/jcem-68-2-374View ArticlePubMedGoogle Scholar
- Engel PC, Jones JB: Caauses and elimination of erratic blanks in enzymatic metabolite assays involving the use of NAD+ in alkaline hydrazine buffers: improved conditions for the assay of L-glutamate, L-lactate, and other metabolites. Anal Biochem. 1978, 88: 475-484. 10.1016/0003-2697(78)90447-5View ArticlePubMedGoogle Scholar
- Espinal J, Challiss RA, Newsholme EA: Effect of adenosine deaminase and an adenosine analogue on insulin sensitivity in soleus muscle of the rat. FEBS Lett. 1983, 158: 103-106. 10.1016/0014-5793(83)80685-1View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.